Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure—a claims data analysis - Takeaways - MDSpire

Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure—a claims data analysis

  • By

  • Lisa–Marie Müller

  • Jonas Krampe

  • Julius L. Katzmann

  • Ulrich Laufs

  • Alexander Kogel

  • July 7, 2026

  • 0 min

Share

  • 1

    Socioeconomic factors influence the risk of heart failure and cardiovascular outcomes, impacting treatment access and quality.

  • 2

    SGLT2 inhibitors are recommended for all heart failure patients, improving outcomes in those with reduced and preserved ejection fraction.

  • 3

    Previous studies indicate that low socioeconomic status correlates with lower prescription rates of guideline-directed therapies.

  • 4

    This study aims to analyze real-world prescription patterns of SGLT2 inhibitors, focusing on socioeconomic factors affecting initiation.

  • 5

    Data from the German Analysis Database and INKAR database will be utilized to assess patient and area-level factors influencing SGLT2i access.

Original Source(s)

Socioeconomic factors and SGLT2 inhibitor initiation in patients with heart failure—a claims data analysis

  • by Lisa–Marie Müller, Jonas Krampe, Julius L. Katzmann, Ulrich Laufs, Alexander Kogel

  • July 7, 2026

Related Content

Patients’ Experiences of Nurse-Led eHealth Interventions for Chronic Heart Failure: Qualitative Systematic Review and Meta-Synthesis

Beyond cardiac fibroblasts: research advances on understanding and targeting intercellular communication networks in cardiac fibrosis

BIRC3-CASP8 axis orchestrates the PANoptosis spectrum: taming the inflammatory storm to prevent post-ischemic heart failure